Sagimet Biosciences Inc. (SGMT) Tops Q2 EPS by 25c

Sagimet Biosciences Inc. (NASDAQ: SGMT) reported Q2 EPS of ($0.25), $0.25 better than the analyst estimate of ($0.50).

For earnings history and earnings-related data on Sagimet Biosciences Inc. (SGMT) click here.

You May Also Be Interested In

• Pizza Hut CEO Aaron Powell resigns
• Credo Technology Group Holding (CRDO) Tops Q1 EPS by 4c; offers guidance
• After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI